Resveratrol derivative or medical application thereof in fibrosis resistance
The invention relates to an application of a resveratrol derivative as shown in a formula I or pharmaceutically acceptable salt thereof in preparation of drugs for treating fibrosis diseases. In the structural formula I, R1 is hydrogen atom or C1-C4 alkyl
-
Paragraph 0037-0038; 0041-0042
(2020/10/14)
Pan-PPAR agonists based on the resveratrol scaffold: Biological evaluation and docking studies